976 
HIV Care and the Incidence of Acute Renal Failure
J Roe, L Campbell, F Ibrahim, B Hendry, and Frank Post*
King`s Coll London, UK
Background: Acute renal failure is an important
complication of HIV infection, yet remains poorly studied. It is unclear
whether HIV care, including HAART and prophylaxis against opportunistic
infections, affects the risk of developing acute renal failure. We studied the
incidence of acute renal failure in a large multi-ethnic cohort of HIV infected
patients.
Methods: All HIV-infected patients attending King’s
College Hospital, London, United Kingdom, who experienced an estimated
glomerular filtration rate (eGFR) <60 mL/minute between January 1998 and December
2005 were studied. Patients were assessed for acute renal failure by applying 3
eGFR-based or serum creatinine-based criteria: confirmed eGFR <60 mL/minute,
nadir eGFR >40% reduced from baseline, and duration of renal failure (eGFR
<60 mL/min) <3 months; or confirmed raised serum creatinine (>120 μM/L
[1.36 mg/dL]), peak serum creatinine >50% increased over baseline, and
duration of renal failure (raised serum creatinine) <3 months. In addition,
patients with chronic kidney disease (eGFR <60 mL/min for >3 months) were
included as acute on chronic renal failure if they experienced a confirmed
>40% reduction in eGFR in <3 months. Acute renal failure episodes were
classified as early-onset if they occurred <3 months of initiating HIV care,
and late-onset if they occurred >3 months after initiating care.
Results: During the study period, 130 of 2274
patients (5.7%) developed 144 episodes of acute renal failure. The etiology of acute
renal failure was diverse and included opportunistic and non-opportunistic
infections, malignancy, or liver disease in 35%, 42%, 17%, and 12% of patients,
accompanied by reduced renal blood flow (70%), use of nonsteroidal
anti-inflammatory drugs (27%), or exposure to potentially nephrotoxic
anti-microbial or anti-neoplastic agents (67%). The incidence rates of
early-onset and late-onset acute renal failure were 19.3 (95%CI 15.4 to 24.1) and
1.1 (0.83 to 1.49) episodes per 100 person-years, respectively (rate ratio 17.4,
12.0 to 25.2, p <0.001). In multivariate analysis, nadir CD4 T cell
count <100 x 109 cells/L (OR 6.7, 2.5 to 18.3), and AIDS (OR 6.7,
3.4 to 13.3) were associated with early-onset acute renal failure, while intravenous
drug use (OR 4.8, 1.3 to 17.7), hepatitis C co-infection (OR 3.4, 1.3 to 8.6),
and nadir CD4 T cell count <100 x 109 cells/L (OR 5.8, 2.5 to 13.4)
were associated with late-onset acute renal failure.
Conclusions: Acute renal failure was common among
patients initiating HIV care, and associated with advanced immunodeficiency.
The incidence of acute renal failure declined more than 10-fold in patients who
had received HIV care for >3 months.
|